Back to results
CompletedPhase 3

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

NCT01179048

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Alabaster, Alabama, United States

+427 additional locations

View on ClinicalTrials.gov
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results — TrialFind